| Group | Total augmented area | Residual particle | New bone | Remaining membrane |
---|---|---|---|---|---|
2 weeks | Control | 4.21 ± 1.52 | - | 0.95 ± 0.81b | - |
EDC | 3.49 ± 1.07 | - | 0.95 ± 0.31b | 5.51 ± 0.73b | |
BG | 10.04 ± 2.03a | 2.39 ± 1.00 | 1.93 ± 0.61b | - | |
B-EDC | 11.49 ± 2.82ab | 3.17 ± 1.05 | 1.98 ± 0.70b | 5.58 ± 0.97b | |
8 weeks | Control | 5.21 ± 1.40 | - | 2.76 ± 0.92b | - |
EDC | 4.23 ± 1.00 | - | 2.11 ± 0.64b | 1.98 ± 1.89b | |
BG | 12.54 ± 1.64a | 2.70 ± 0.73 | 4.76 ± 1.61ab | - | |
B-EDC | 14.59 ± 3.13ab | 2.84 ± 0.66 | 5.10 ± 1.68ab | 1.47 ± 1.65b |